FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel compounds of the general formula (I): R1-O(O)C-CH2-(R)Cgl-Aze-Pab-R2 where R1 means -R3 or -A1-C(O)N-(R4)R5 or -A1-C(O)O-R4; A1 means C1-5-alkylene; R2 (that replaces one of hydrogen atom in amidine unit in Pab-H) means OH, OC(O)-R6, C(O)O-R7 or C(O)OCH((R8))OC(O)-R9; R3 means H, C1-10-alkyl or C1-3-alkyl-phenyl (being the latter group is substituted possibly with C1-6-alkyl); R4 and R5 mean independently H, C1-6-alkyl or when R1 means -A1-C(O)N-(R4)R5 in common with nitrogen atom to which they are bound mean pyrrolidinyl group; R6 means C1-17-alkyl or phenyl; R7 means phenyl, C1-3-alkylphenyl (being two latter groups are substituted possibly with C1-6-alkyl, C1-6-alkoxy-group or nitro-group) or C1-12-alkyl (being the latter group is substituted possibly with C1-6-alkoxy-group or halogen atom); R8 means H or C1-4-alkyl and R9 means phenyl or C1-8-alkyl being alkyl groups that can be presented by R3,R4,R5,R6,R7 and R9 can be linear ones or in the case of sufficient amount of carbon atoms they can be branched, cyclic or partially cyclic, saturated or unsaturated ones and can be broken by oxygen atom under condition that when R1 means R3 then R3 means benzyl, methyl, ethyl, n-butyl or n-hexyl group and R2 means C(O)O-R7 and then R7 does not mean benzyl; or its pharmaceutically acceptable salt. New compounds relate to pharmaceutically useful prodrugs of pharmaceutically active compounds that are competitive inhibitors of trypsin-like serine proteases, especially, thrombin. EFFECT: new compounds indicated above, valuable medicinal properties. 66 cl, 1 tbl, 70 ex
Title |
Year |
Author |
Number |
NOVEL DERIVATIVES OF MANDELIC ACID AND THEIR USING AS THROMBIN INHIBITORS |
2001 |
- Ingkhardt Tord
- Jokhansson Anders
- Svensson Arne
|
RU2300521C2 |
PHARMACEUTICAL COMPOSITION |
2002 |
- Gaik-Lim Kkhoo Sintija
- Gustafsson Khelena
|
RU2323006C2 |
ALMOND ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITOR |
2002 |
- Ingkhardt Tor
- Jokhansson Anders
- Svensson Arne
|
RU2341516C2 |
PHARMACEUTICAL PREPARATION WITH MODIFIED ELUTION |
2003 |
- Magnusson Anders
- Tune Mikaehl'
|
RU2352323C2 |
TIME-RELEASE PHARMACEUTICAL COMPOSITION AND USE THEREOF |
2003 |
- Magnusson Anders
- Tune Mikaehl'
|
RU2474416C2 |
THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF TREATMENT, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PROTECTED DERIVATIVE |
1996 |
- Gustafsson David
- Njustrem Jan-Ehrik
|
RU2176645C2 |
PHARMACEUTICAL PREPARATION WITH IMMEDIATE RELEASE |
2003 |
- Abrakhmsen Alami Susanna
- Ingkhardt Tord
- Magnusson Anders
- Sigfridsson Karl-Gustaf
- Tune Mikaehl'
|
RU2351314C2 |
THROMBIN INHIBITOR-CONTAINING AQUEOUS SOLUTION FOR NONPARENTERAL ADMINISTRATION SHOWING STABILITY AT STORAGE |
1995 |
- Ulla St'Ernfel'T
- Mats Sundgren
|
RU2164803C2 |
PEPTIDE DERIVATIVES, THEIR STEREOISOMERS OR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING ANTITHROMBOSIS, ANTICOAGULATING OR ANTI-INFLAMMATORY ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF SUPPRESSION OF THROMBIN ACTIVITY, METHOD OF INHIBITION OF KININOGENASES ACTIVITY, USE OF COMPOUNDS AS PARENT SUBSTANCES FOR SYNTHESIS OF THROMBIN INHIBITOR |
1994 |
- Karl Tomas Antonsson
- Rut Ehl'Vju Bjulund
- Nil'S David Gustafsson
- Nil'S Olov Ingemar Nil'Sson
|
RU2142469C1 |
AZABICYCLOOCTANE DERIVATIVE, PHARMACEUTICAL PREPARATIONS, METHOD FOR PROPHYLAXIS OR TREATMENT, METHODS FOR PREPARING COMPOUNDS, COMPOUNDS |
2000 |
- B'Ersne Magnus
- Ponten Frit'Of
- Strandlund Jert
- Svensson Peder
|
RU2262505C2 |